S1034 HCPCS Level II code: Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and…
S1034 is the HCPCS code for “Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all…” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
S1034Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices
Short description: Art pancreas system
HCPCS · United States
Medicare details
The indicators CMS publishes with S1034 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Added
- Jul 1, 2014
Where S1034 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Active code S1034Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code S1034 mean?
S1034 is the HCPCS code for “Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover S1034?
CMS lists S1034’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S1034
All S codesS1001Deluxe item, patient aware (list in addition to code for basic item)S1002Customized item (list in addition to code for basic item)S1015Iv tubing extension setS1016Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxelS1030Continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)S1031Continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)S1035Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device systemS1036Transmitter; external, for use with artificial pancreas device systemS1037Receiver (monitor); external, for use with artificial pancreas device systemS1040Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)S1090Mometasone furoate sinus implant, 370 microgramsS1091Stent, non-coronary, temporary, with delivery system (propel)